These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1892484)

  • 1. Effects of probucol on plasma lipoprotein subfractions and activities of lipoprotein lipase and hepatic triglyceride lipase.
    Homma Y; Moriguchi EH; Sakane H; Ozawa H; Nakamura H; Goto Y
    Atherosclerosis; 1991 Jun; 88(2-3):175-81. PubMed ID: 1892484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of eicosapentaenoic acid on plasma lipoprotein subfractions and activities of lecithin:cholesterol acyltransferase and lipid transfer protein.
    Homma Y; Ohshima K; Yamaguchi H; Nakamura H; Araki G; Goto Y
    Atherosclerosis; 1991 Nov; 91(1-2):145-53. PubMed ID: 1811549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma post-heparin lipase activities in the HERITAGE Family Study: the reproducibility, gender differences, and associations with lipoprotein levels. HEalth, RIsk factors, exercise Training and GEnetics.
    Després JP; Gagnon J; Bergeron J; Couillard C; Leon AS; Rao DC; Skinner JS; Wilmore JH; Bouchard C
    Clin Biochem; 1999 Apr; 32(3):157-65. PubMed ID: 10383074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-heparin plasma lipoprotein and hepatic lipases. Relationships to high density lipoprotein cholesterol and to apolipoprotein CII in familial hyperalphalipoproteinemic and in normal subjects.
    Taskinen MR; Glueck CJ; Kashyap ML; Srivastava LS; Hynd BA; Perisutti G; Robinson K; Kinnunen PJ; Kuusi T
    Atherosclerosis; 1980 Oct; 37(2):247-56. PubMed ID: 7426098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia.
    Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Mikami Y; Mikami Y; Nakamura H
    Atherosclerosis; 1994 Apr; 106(2):191-201. PubMed ID: 8060379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the rat.
    Strandberg T; Kuusi T; Tilvis R; Miettinen TA
    Atherosclerosis; 1981; 40(3-4):193-201. PubMed ID: 7332600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired metabolism of high density lipoprotein in uremic patients.
    Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
    Kidney Int; 1992 Jun; 41(6):1653-61. PubMed ID: 1501422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.
    Oi K; Hirano T; Sakai S; Kawaguchi Y; Hosoya T
    Kidney Int Suppl; 1999 Jul; 71():S227-8. PubMed ID: 10412783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities.
    Chiesa G; Michelagnoli S; Cassinotti M; Gianfranceschi G; Werba JP; Pazzucconi F; Sirtori CR; Franceschini G
    Metabolism; 1993 Feb; 42(2):229-35. PubMed ID: 8474321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
    Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
    Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoproteins and lipolytic enzyme activities during endurance training in sedentary men: changes in high-density lipoprotein subfractions and composition.
    Stubbe I; Hansson P; Gustafson A; Nilsson-Ehle P
    Metabolism; 1983 Dec; 32(12):1120-8. PubMed ID: 6417447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lipoprotein lipase and hepatic triglyceride lipase activity on the distribution of apolipoprotein E among the plasma lipoproteins.
    Gibson JC; Brown WV
    Atherosclerosis; 1988 Sep; 73(1):45-55. PubMed ID: 3178931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination therapy with estrogen plus simvastatin on lipoprotein metabolism in postmenopausal women with type IIa hypercholesterolemia.
    Wakatsuki A; Okatani Y; Ikenoue N
    Atherosclerosis; 2000 May; 150(1):103-11. PubMed ID: 10781640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Ozawa H; Sakane H; Nakamura H
    Atherosclerosis; 1997 Mar; 129(2):241-8. PubMed ID: 9105567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulating effect of intermediate-density lipoproteins (IDL) from hyperlipemic plasma on hepatic lipase.
    Dzien A; Breier C; Lisch HJ; Braunsteiner H
    Klin Wochenschr; 1986 Jun; 64(11):530-3. PubMed ID: 3724000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives.
    Fellin R; Baggio G; Poli A; Augustin J; Baiocchi MR; Baldo G; Sinigaglia M; Greten H; Crepaldi G
    Atherosclerosis; 1983 Oct; 49(1):55-68. PubMed ID: 6651913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.
    Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.